GlaxoSmithKline has been granted priority review status in Japan for adefovir dipivoxil [Hepsera; licensed from Gilead Sciences]

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1437, 2004-01, pp. : 21-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An amended lawsuit has been filed against pharmaceutical giant GlaxoSmithKline

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 388, 2002-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Lamivudine/abacavir [Kivexa; GlaxoSmithKline] has been launched in the UK and Germany

By  

Inpharma, Vol. 1, Iss. 1470, 2005-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Injectable fomepizole [`Antizol'; Paladin Labs] has been granted priority review status in Canada

By  

Inpharma, Vol. 1, Iss. 1225, 2000-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

Schering-Plough's peginterferon (PEG IFN)- -2b plus ribavirin [Peg-Intron plus Rebetol] has been granted priority review status in Japan for a new indication

By  

Inpharma, Vol. 1, Iss. 1495, 2005-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

GlaxoSmithKline (GSK) has asked government healthcare officials from several nations for opinions on which investigational drugs should be prioritised

By  

Inpharma, Vol. 1, Iss. 1646, 2008-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite